Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PSF, CMG

COVID-19 - State of emergency renewed for the urban agglomeration of Montréal


MONTRÉAL, Nov. 23, 2020 /CNW Telbec/ - In accordance with the Civil Protection Act, Montréal's executive committee has renewed the state of emergency for the urban agglomeration of Montréal on November 23, for a period of five days. 

The local state of emergency, which was declared on March 27, grants exceptional powers to the urban agglomeration, enabling it to respond to the current pandemic across its territory. In particular, it gives the urban agglomeration the power to mobilize the necessary resources and workforce to fight COVID-19. 

The urban agglomeration of Montréal continues to collaborate closely with its team of experts from its emergency response coordination centre, the regional public health department and the healthcare network, in order to fight the spread of COVID-19. 

Read more: Civil Protection Act

Montréal's Web portal: montreal.ca

SOURCE Ville de Montréal


These press releases may also interest you

at 23:00
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:33
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....



News published on and distributed by: